SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-169821
Filing Date
2017-05-15
Accepted
2017-05-15 08:21:56
Documents
3
Period of Report
2017-05-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d390320d8k.htm 8-K 15917
2 EX-99.1 d390320dex991.htm EX-99.1 36488
3 GRAPHIC g390320g90m14.jpg GRAPHIC 4845
  Complete submission text file 0001193125-17-169821.txt   60492
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

IRS No.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31791 | Film No.: 17841250
SIC: 2834 Pharmaceutical Preparations